XML 19 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED BALANCE SHEETS (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2012
Jun. 30, 2012
CURRENT ASSETS:    
Cash and cash equivalents $ 38,751 $ 9,389
Short term bank deposits 21,434 21,397
Marketable securities 8,129 7,023
Other accounts receivable 1,668 383
Total current assets 69,982 38,192
LONG-TERM ASSETS:    
Long-term deposits and restricted deposits 984 1,287
Advance payment for leasehold improvements 3,428 2,400
Property and equipment, net 6,440 5,019
Severance pay fund 571 522
Other long term assets 39   
Total long-term assets 11,462 9,228
Total assets 81,444 47,420
CURRENT LIABILITIES    
Trade payables 1,696 1,368
Accrued expenses 1,069 922
Deferred revenues 779 779
Advance payment from United Therapeutics 959 1,576
Other accounts payable 729 877
Total current liabilities 5,232 5,522
LONG-TERM LIABILITIES    
Deferred revenues 3,310 3,505
Accrued severance pay 709 651
Total long-term liabilities 4,019 4,156
COMMITMENTS AND CONTINGENCIES      
STOCKHOLDERS' EQUITY    
Common stock $0.00001 par value: Authorized: 100,000,000 shares Issued and outstanding: 57,257,230 shares as of September 30, 2012, 46,448,051 shares as of June 30, 2012      
Additional paid-in capital 141,836 103,619
Accumulated deficit (69,742) (65,747)
Other comprehensive gain (loss) 99 (130)
Total stockholders' equity 72,193 37,742
Total liabilities and stockholders' equity $ 81,444 $ 47,420